Skip to main content
. 2019 Apr 8;14:2515–2531. doi: 10.2147/IJN.S190502

Figure 2.

Figure 2

(A) Ramp graph and (B) contour plot of desirability for numerically optimized NAT-SLN formulations F1 and F2.

Abbreviations: NAT, natamycin; NAT-SLN, NAT solid lipid nanoparticle.